ARQULE INC
DelistedCIK 1019695fmd_18CVGMW2KC3X069V0M8Q6RWH0VManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2019, 39 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | 49 | 47 | 45 | 34 | 28 | 22 | 16 | 20 | 19 | 29 |
| Gain on sale of real estate | – | – | – | – | – | 0 | 0 | 0 | – | – |
| Operating income | (38) | (31) | (11) | (11) | (25) | (24) | (14) | (23) | (27) | (14) |
| Interest expense | 1 | 0 | 0 | 0 | 0 | 0 | – | – | 2 | 2 |
| Interest and investment income | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Other non-operating income (expense) | 2 | 0 | 0 | 0 | – | – | 0 | 0 | (1) | (2) |
| Income before taxes | (36) | (31) | (11) | (11) | (25) | (23) | (14) | (23) | (29) | (15) |
| Income tax expense | 1 | (1) | – | – | – | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (36) | (30) | – | – | – | – | (14) | (23) | (29) | (15) |
| Net income | (36) | (30) | (11) | (11) | (25) | (23) | (14) | (23) | (29) | (15) |